Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2009 1
2010 2
2011 5
2012 3
2013 7
2014 3
2015 6
2016 4
2017 2
2018 6
2019 6
2020 8
2021 5
2022 6
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis.
Gentile A, Musella A, De Vito F, Rizzo FR, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G. Gentile A, et al. Among authors: mandolesi g. Front Immunol. 2019 Sep 13;10:2197. doi: 10.3389/fimmu.2019.02197. eCollection 2019. Front Immunol. 2019. PMID: 31572399 Free PMC article. Review.
Re-Examining the Role of TNF in MS Pathogenesis and Therapy.
Fresegna D, Bullitta S, Musella A, Rizzo FR, De Vito F, Guadalupi L, Caioli S, Balletta S, Sanna K, Dolcetti E, Vanni V, Bruno A, Buttari F, Stampanoni Bassi M, Mandolesi G, Centonze D, Gentile A. Fresegna D, et al. Among authors: mandolesi g. Cells. 2020 Oct 14;9(10):2290. doi: 10.3390/cells9102290. Cells. 2020. PMID: 33066433 Free PMC article. Review.
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.
De Vito F, Balletta S, Caioli S, Musella A, Guadalupi L, Vanni V, Fresegna D, Bassi MS, Gilio L, Sanna K, Gentile A, Bruno A, Dolcetti E, Buttari F, Pavone L, Furlan R, Finardi A, Perlas E, Hornstein E, Centonze D, Mandolesi G. De Vito F, et al. Among authors: mandolesi g. Curr Neuropharmacol. 2023;21(12):2567-2582. doi: 10.2174/1570159X21666230404103914. Curr Neuropharmacol. 2023. PMID: 37021418 Free PMC article.
Osteopontin Is Associated with Multiple Sclerosis Relapses.
Stampanoni Bassi M, Buttari F, Gilio L, Iezzi E, Galifi G, Carbone F, Micillo T, Dolcetti E, Azzolini F, Bruno A, Borrelli A, Mandolesi G, Rovella V, Storto M, Finardi A, Furlan R, Centonze D, Matarese G. Stampanoni Bassi M, et al. Among authors: mandolesi g. Biomedicines. 2023 Jan 11;11(1):178. doi: 10.3390/biomedicines11010178. Biomedicines. 2023. PMID: 36672686 Free PMC article.
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Bruno A, Buttari F, Dolcetti E, Azzolini F, Borrelli A, Lauritano G, Di Caprio V, Rizzo FR, Gilio L, Galifi G, Furlan R, Finardi A, Guadalupi L, Musella A, Mandolesi G, Centonze D, Stampanoni Bassi M. Bruno A, et al. Among authors: mandolesi g. Mult Scler. 2023 Oct;29(11-12):1383-1392. doi: 10.1177/13524585231197928. Epub 2023 Sep 12. Mult Scler. 2023. PMID: 37698019
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting.
Musella A, Fresegna D, Rizzo FR, Gentile A, De Vito F, Caioli S, Guadalupi L, Bruno A, Dolcetti E, Buttari F, Bullitta S, Vanni V, Centonze D, Mandolesi G. Musella A, et al. Among authors: mandolesi g. Expert Opin Ther Targets. 2020 Jan;24(1):37-46. doi: 10.1080/14728222.2020.1709823. Epub 2020 Jan 3. Expert Opin Ther Targets. 2020. PMID: 31899994 Review.
73 results